Long-Term Use of Pramipexole in Bipolar Depression: A Naturalistic Retrospective Chart Review
- 172 Downloads
A naturalistic retrospective chart review of all patients given pramipexole for bipolar depression in addition to their mood stabilizers was undertaken. Sixteen patients were followed for an average of 6.7 ± SD 9.0 months. Half of the patients stopped the pramipexole an average of 2 months after starting it. For all patients, depressed mood, and the total profile of depressive symptoms improved significantly within 4 weeks and remained significantly improved for as long as 36 weeks. Both global function (GAF), and global impression (CGI) improved with pramipexole. Irritability and insomnia both increased slightly initially, and then subsided. There were no changes in mania ratings for up to 36 months. Long-term outcome of adjunctive pramipexole appears to be adequate, with apparent maintenance of effect for over 9 months.
KeywordsBipolar depression Bipolar disorder Long-term outcome Pramipexole
- 1.American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders-Text Revision, 4th edn., revised. Arlington, Virginia, American Psychiatric Press, 2000Google Scholar
- 8.El-Mallakh RS, Karippot A, Ghaemi SN: Antidepressants in Bipolar Depression. In: El-Mallakh RS, Ghaemi SN (Eds) Bipolar Depression: A Comprehensive Guide. Washington, DC, American Psychiatric Publishing, Inc., pp. 167–183, 2006Google Scholar
- 12.Ghaemi SN, Ostacher MM, El-Mallakh RS, Borrelli D, Baldassano CF, Kelley ME, Filkowski MM, Hennen J, Sachs G, Goodwin FK, Baldessarini RJ: A randomized clinical trial of long-term effectiveness and safety of modern antidepressants combined with mood-stabilizers. Journal of Clinical Psychiatry, 2010 (in press)Google Scholar
- 23.Roberts RJ, Yang M, El-Mallakh RS: Validity and reliability of the RAPID (Rapid Psychiatric Interview Data) scale. Presented at the Eighth International Conference on Bipolar Disorder, Pittsburgh, Pennsylvania, pp. 25–27, 2009Google Scholar